PRF1 and cancer: After the binding with their ligands, NK cells can kill cancer cells through different mechanisms, including direct lysis mediated by perforin, direct killing through death receptor-mediated pathways (i.e. TRAIL and FasL), through the release of cytokines in the TME or through ADCC (22, 23) (Figure 1).